Physician profile
Ellen Sterman
NPI 1033265897
$4,978.35
in general payments reported to CMS, 2019-2025
40 companies · $623 in 2025
The $623 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $711 · 2021: $770 · 2022: $757 · 2023: $1,122 · 2024: $419 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,085 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,084.55 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $605.44 | 2021-2025 | |
| Abbvie INC. | $510.62 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Therapeuticsmd, INC. | $402.26 | 2019-2022 | |
| Exeltis, USA INC. | $379.04 | 2020-2025 | Slynd |
| Coopersurgical, INC. | $303.32 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $265.16 | 2019-2025 | Veozah |
| Organon LLC | $243.86 | 2021-2024 | |
| Daiichi Sankyo INC. | $221.38 | 2019-2023 | Injectafer |
| Amgen INC. | $192.37 | 2019-2025 | Evenity, Prolia |
| Agile Therapeutics, INC. | $180.53 | 2021-2024 | Twirla |
| Merck Sharp & Dohme LLC | $135.24 | 2019-2024 | Gardasil 9, Gardasil |
| Pfizer INC. | $134.63 | 2019-2024 | |
| Avion Pharmaceuticals | $132.45 | 2019-2021 | |
| Medical Device Business Services, INC. | $124.99 | 2025 | Enseal |
| Medtronic, INC. | $98.45 | 2023-2025 | Truclear, Ligasure |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $90.87 | 2019-2025 | Aptima, Fluent Fluid Management System |
| Millicent US INC | $90.50 | 2020-2025 | Femlyv, Femring, Intrarosa |
| Gilead Sciences, INC. | $86.58 | 2022-2023 | |
| Exact Sciences Corporation | $85.25 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $84.74 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $81.15 | 2020-2024 | |
| Mylan Pharmaceuticals INC. | $77.52 | 2021-2022 | |
| Evofem Biosciences, INC. | $50.62 | 2020-2024 | |
| Biogen, INC. | $44.95 | 2023-2024 | |
| Mission Pharmacal Company | $37.49 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $37.18 | 2019-2020 | |
| Roche Diagnostics Corporation | $33.10 | 2021 | |
| Axsome Therapeutics, INC. | $31.37 | 2023 | Auvelity |
| Zyla Life Sciences, INC. | $30.16 | 2020 | |
| Scynexis, INC. | $26.33 | 2022 | |
| Vertical Pharmaceuticals, LLC | $26.22 | 2019 | |
| Lilly USA, LLC | $18.39 | 2021 | |
| Allergan, INC. | $16.76 | 2019 | |
| Shield Therapeutics INC | $15.88 | 2023 | Accrufer |
| Smith+Nephew, INC. | $14.76 | 2022 | |
| Cepheid | $14.33 | 2023 | |
| Amarin Pharma, INC. | $13.99 | 2019 | |
| Duchesnay USA Incorporated | $13.68 | 2019 | |
| Meditrina | $13.59 | 2021 | |
| Novo Nordisk INC | $13.20 | 2023 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Sterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.